Terms: = Uterine cancer AND ATIC, IMPCHASE, 471, ENSG00000138363, AICARFT, P31939, PURH AND Treatment
25 results:
1. Pembrolizumab or Placebo Plus Chemotherapy With or Without Bevacizumab for Persistent, Recurrent, or Metastatic Cervical cancer: Subgroup Analyses From the KEYNOTE-826 Randomized Clinical Trial.
Tewari KS; Colombo N; Monk BJ; Dubot C; Cáceres MV; Hasegawa K; Shapira-Frommer R; Salman P; Yañez E; Gümüs M; Olivera Hurtado de Mendoza M; Samouëlian V; Castonguay V; Arkhipov A; Tekin C; Li K; Toker S; Keefe SM; Lorusso D
JAMA Oncol; 2024 Feb; 10(2):185-192. PubMed ID: 38095881
[TBL] [Abstract] [Full Text] [Related]
2. Causes of death in endometrial cancer survivors: A Surveillance, Epidemiology, and End Result-based analysis.
Xue Q; Che W; Xue L; Zhang X; Wang X; Lyu J
Cancer Med; 2023 May; 12(9):10917-10930. PubMed ID: 36924355
[TBL] [Abstract] [Full Text] [Related]
3. Cemiplimab as Second-Line Therapy for Patients with Recurrent Cervical cancer: A United States-based Cost-effectiveness Analysis.
Liu K; Zhu Y; Zhou Y; Zhu H
Adv Ther; 2023 Apr; 40(4):1838-1849. PubMed ID: 36870042
[TBL] [Abstract] [Full Text] [Related]
4. Disparities in Survival and Comorbidity Burden Between Asian and Native Hawaiian and Other Pacific Islander Patients With cancer.
Taparra K; Qu V; Pollom E
JAMA Netw Open; 2022 Aug; 5(8):e2226327. PubMed ID: 35960520
[TBL] [Abstract] [Full Text] [Related]
5. Practice patterns and 90-day treatment-related morbidity in early-stage cervical cancer.
Bogani G; Donato VD; Scambia G; Landoni F; Ghezzi F; Muzii L; Panici PB; Raspagliesi F;
Gynecol Oncol; 2022 Sep; 166(3):561-566. PubMed ID: 35909005
[TBL] [Abstract] [Full Text] [Related]
6. Adverse Urinary System Outcomes among Older Women with Endometrial cancer.
Anderson C; Lund JL; Park J; Brewster W; Bae-Jump V; Olshan AF; Nichols HB
Cancer Epidemiol Biomarkers Prev; 2022 Jul; 31(7):1508. PubMed ID: 35775217
[TBL] [Abstract] [Full Text] [Related]
7. Frequency of Mismatch Repair Deficiency/High Microsatellite Instability and Its Role as a Predictive Biomarker of Response to Immune Checkpoint Inhibitors in Gynecologic cancers.
Noh JJ; Kim MK; Choi MC; Lee JW; Park H; Jung SG; Joo WD; Song SH; Lee C
Cancer Res Treat; 2022 Oct; 54(4):1200-1208. PubMed ID: 34902958
[TBL] [Abstract] [Full Text] [Related]
8. Comparison Between 360° 3-D Transvaginal Ultrasound and Magnetic Resonance Imaging for Assessment of Vaginal Invasion in Cervical cancer: A Preliminary Report.
Zhu Y; Lu M; Dai KJ; Liu C; He R
Ultrasound Med Biol; 2021 Aug; 47(8):2250-2257. PubMed ID: 34020846
[TBL] [Abstract] [Full Text] [Related]
9. Preferences for follow up in long-term survivors after cervical cancer.
Vistad I; Lindemann K; Bentzen AG; Dahl AA; Steen R; Kiserud C
Acta Obstet Gynecol Scand; 2020 Sep; 99(9):1253-1259. PubMed ID: 32232835
[TBL] [Abstract] [Full Text] [Related]
10. [Discussion on the diagnosis and treatment of high-grade squamous intraepithelial lesions in post-menopausal women].
Cao QW; You ZX; Qian XY; Heng D; Tang MY
Zhonghua Fu Chan Ke Za Zhi; 2019 Jun; 54(6):393-398. PubMed ID: 31262123
[No Abstract] [Full Text] [Related]
11. Significance of postmenopausal uterine leiomyomas: Focus on variants.
Oi Y; Katayama K; Hirata G; Ishidera Y; Yoshida H; Shigeta H
J Obstet Gynaecol Res; 2018 Aug; 44(8):1445-1450. PubMed ID: 29845685
[TBL] [Abstract] [Full Text] [Related]
12. treatment failure following excision therapy of CIN: the impact of direct colposcopic vision during procedure.
Heineman M; Mancini J; Villeret J; Agostini A; Houvenaeghel G; Boubli L; Carcopino X
Arch Gynecol Obstet; 2016 Apr; 293(4):825-31. PubMed ID: 26404447
[TBL] [Abstract] [Full Text] [Related]
13. Pulsed-dose rate image-guided adaptive brachytherapy in cervical cancer: Dose-volume effect relationships for the rectum and bladder.
Mazeron R; Maroun P; Castelnau-Marchand P; Dumas I; del Campo ER; Cao K; Slocker-Escarpa A; M'Bagui R; Martinetti F; Tailleur A; Guemnie-Tafo A; Morice P; Chargari C; Lefkopoulos D; Haie-Meder C
Radiother Oncol; 2015 Aug; 116(2):226-32. PubMed ID: 26164773
[TBL] [Abstract] [Full Text] [Related]
14. Risk of preterm delivery with increasing depth of excision for cervical intraepithelial neoplasia in England: nested case-control study.
Castanon A; Landy R; Brocklehurst P; Evans H; Peebles D; Singh N; Walker P; Patnick J; Sasieni P;
BMJ; 2014 Nov; 349():g6223. PubMed ID: 25378384
[TBL] [Abstract] [Full Text] [Related]
15. Synchronous primary cancers of the endometrium and ovary in young women: a Korean Gynecologic Oncology Group Study.
Song T; Seong SJ; Bae DS; Suh DH; Kim DY; Lee KH; Lim MC; Lee TS
Gynecol Oncol; 2013 Dec; 131(3):624-8. PubMed ID: 24051220
[TBL] [Abstract] [Full Text] [Related]
16. MR thermometry analysis of sonication accuracy and safety margin of volumetric MR imaging-guided high-intensity focused ultrasound ablation of symptomatic uterine fibroids.
Kim YS; Trillaud H; Rhim H; Lim HK; Mali W; Voogt M; Barkhausen J; Eckey T; Köhler MO; Keserci B; Mougenot C; Sokka SD; Soini J; Nieminen HJ
Radiology; 2012 Nov; 265(2):627-37. PubMed ID: 23012465
[TBL] [Abstract] [Full Text] [Related]
17. Demographic differences in stage at diagnosis and cervical cancer survival in New Zealand, 1994-2005.
Brewer N; Pearce N; Jeffreys M; White P; Ellison-Loschmann L
J Womens Health (Larchmt); 2009 Jul; 18(7):955-63. PubMed ID: 19580365
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic factors for uterine cancer in reproductive-aged women.
Lee NK; Cheung MK; Shin JY; Husain A; Teng NN; Berek JS; Kapp DS; Osann K; Chan JK
Obstet Gynecol; 2007 Mar; 109(3):655-62. PubMed ID: 17329517
[TBL] [Abstract] [Full Text] [Related]
19. What is the most cost-effective population-based cancer screening program for Chinese women?
Woo PP; Kim JJ; Leung GM
J Clin Oncol; 2007 Feb; 25(6):617-24. PubMed ID: 17308266
[TBL] [Abstract] [Full Text] [Related]
20. [Case report of ultrasonographic findings in developing choriocarcinoma].
Nikolić B; Lazić J; Lacković V
Med Arh; 2006; 60(4):269-70. PubMed ID: 16761526
[TBL] [Abstract] [Full Text] [Related]
[Next]
